What happens if the clinical trial treatment for Ovarian Cancer doesn't work
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
What Happens If Your Ovarian Cancer Clinical Trial Treatment Doesn't Work
This is an important question to ask before enrolling in any clinical trial. Let me explain what typically happens and what you should know.
The Clinical Trial Framework
According to NCCN Guidelines, clinical trials are structured in phases, and your treatment team has specific protocols for monitoring how well the treatment is working:
How doctors monitor progress:
- Regular imaging scans (CT, PET, or ultrasound) to measure tumor size
- Blood tests, including CA-125 levels (the key biomarker for ovarian cancer)
- Physical exams to assess your overall condition
- Symptom tracking to evaluate how you're feeling
The research team will establish a timeline for these assessments—often every 4-8 weeks—so they can detect early whether the treatment is having the desired effect.
If the Treatment Isn't Working
You have options and protections:
According to NCCN Guidelines for clinical trials, here's what typically happens:
-
You can leave the trial at any time - This is a fundamental right. You're not locked into a clinical trial if it's not working for you. You can seek treatment outside the trial whenever you choose.
-
Your doctor will discuss other treatment options - If the experimental treatment isn't effective, your oncology team will pivot to alternative approaches. This might include:
- Standard chemotherapy regimens
- Different targeted therapies (like PARP inhibitors if you have BRCA mutations)
- Other clinical trials you might be eligible for
- Combination approaches
-
Continued monitoring and support - Even if you leave the trial, your medical team continues to care for you and help manage your cancer.
Important Questions to Ask BEFORE Enrolling
According to NCCN Guidelines, you should specifically ask your treatment team:
-
"How will you know if the treatment is working?" - Understand the specific markers and timeline they'll use to evaluate response.
-
"Will I be able to get other treatment if this doesn't work?" - Confirm that leaving the trial and pursuing alternative treatments is always an option.
-
"How often will you assess whether the treatment is working?" - Know how frequently they'll check your progress.
-
"What happens if I need to stop the trial?" - Understand the process for discontinuing and what support continues.
-
"Are there other clinical trials available if this one doesn't work for me?" - Learn about backup options early, since new trials are constantly becoming available.
Real-World Context for Ovarian Cancer
The sources mention that ovarian cancer specialists and surgeons are particularly collaborative about precision medicine approaches. According to the webinar on functional profiling, ovarian cancer oncologists understand the importance of testing tumor tissue to guide treatment decisions—which means they're often open to adaptive strategies if initial treatments aren't working.
One case study mentioned showed an ovarian cancer patient whose CA-125 levels (the standard ovarian cancer marker) improved significantly with guided therapy, demonstrating that when treatments are selected based on tumor testing, response rates can be meaningful.
The Bottom Line
Clinical trials are not a one-way commitment. You maintain control over your treatment decisions. If the experimental approach isn't working, you have:
- The right to exit the trial
- Access to your oncologist's expertise in selecting next-step treatments
- Potentially access to other clinical trials
- Continued supportive care from your medical team
The key is having these conversations upfront so you understand the monitoring plan and your options if the treatment isn't effective.
Questions to Bring to Your Oncology Team
- How will we measure whether this trial treatment is working for my specific ovarian cancer?
- What is the timeline for determining if it's effective?
- If it's not working, what are my next treatment options?
- Can I stay in the trial while exploring other options, or do I need to choose?
- Are there other clinical trials I should know about as backup options?
- How will you support me if I decide to leave the trial?
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Ovarian Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Ovarian Cancer patients
Have your records handy? Upload them for a deeper, personalized analysis →